Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Sinorhizobium medicae NADPH-dependent 7-cyano-7-deazaguanine reductase (queF) CSB-YP411834STV
CSB-EP411834STV
CSB-BP411834STV
CSB-MP411834STV
CSB-EP411834STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae 3-demethylubiquinone-9 3-methyltransferase (ubiG) CSB-YP411835STV
CSB-EP411835STV
CSB-BP411835STV
CSB-MP411835STV
CSB-EP411835STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha (accA) CSB-YP411836STV
CSB-EP411836STV
CSB-BP411836STV
CSB-MP411836STV
CSB-EP411836STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae Phosphoglycerate kinase (pgk) CSB-YP411837STV
CSB-EP411837STV
CSB-BP411837STV
CSB-MP411837STV
CSB-EP411837STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae Xylose isomerase (xylA) CSB-YP411838STV
CSB-EP411838STV
CSB-BP411838STV
CSB-MP411838STV
CSB-EP411838STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae Glutamate 5-kinase (proB) CSB-YP411839STV
CSB-EP411839STV
CSB-BP411839STV
CSB-MP411839STV
CSB-EP411839STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae 3-isopropylmalate dehydratase large subunit (leuC) CSB-YP411840STV
CSB-EP411840STV
CSB-BP411840STV
CSB-MP411840STV
CSB-EP411840STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae 30S ribosomal protein S16 (rpsP) CSB-YP411841STV
CSB-EP411841STV
CSB-BP411841STV
CSB-MP411841STV
CSB-EP411841STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae Leucine--tRNA ligase (leuS), partial CSB-YP411842STV
CSB-EP411842STV
CSB-BP411842STV
CSB-MP411842STV
CSB-EP411842STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae Shikimate dehydrogenase (aroE) CSB-YP411843STV
CSB-EP411843STV
CSB-BP411843STV
CSB-MP411843STV
CSB-EP411843STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae ATP-dependent protease subunit HslV (hslV) CSB-YP411844STV
CSB-EP411844STV
CSB-BP411844STV
CSB-MP411844STV
CSB-EP411844STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae Uracil phosphoribosyltransferase (upp) CSB-YP411845STV
CSB-EP411845STV
CSB-BP411845STV
CSB-MP411845STV
CSB-EP411845STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB) CSB-YP411846STV
CSB-EP411846STV
CSB-BP411846STV
CSB-MP411846STV
CSB-EP411846STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase (fabA) CSB-YP411847STV
CSB-EP411847STV
CSB-BP411847STV
CSB-MP411847STV
CSB-EP411847STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae Ubiquinone/menaquinone biosynthesis methyltransferase ubiE (ubiE) CSB-YP411848STV
CSB-EP411848STV
CSB-BP411848STV
CSB-MP411848STV
CSB-EP411848STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae Probable potassium transport system protein kup 2 (kup2), partial CSB-YP411849STV
CSB-EP411849STV
CSB-BP411849STV
CSB-MP411849STV
CSB-EP411849STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii Type-2 serine--tRNA ligase (serS), partial CSB-YP411850MNS
CSB-EP411850MNS
CSB-BP411850MNS
CSB-MP411850MNS
CSB-EP411850MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii tRNA (pseudouridine (54)-N (1))-methyltransferase CSB-YP411851MNS
CSB-EP411851MNS
CSB-BP411851MNS
CSB-MP411851MNS
CSB-EP411851MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B CSB-YP411852MNS
CSB-EP411852MNS
CSB-BP411852MNS
CSB-MP411852MNS
CSB-EP411852MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii N- (5'-phosphoribosyl)anthranilate isomerase CSB-YP411853MNS
CSB-EP411853MNS
CSB-BP411853MNS
CSB-MP411853MNS
CSB-EP411853MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>